You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 19, 2025

Drug Price Trends for SB POVIDONE-IODINE


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for SB POVIDONE-IODINE

Market Analysis and Price Projections for Povidone-Iodine

Introduction to Povidone-Iodine

Povidone-iodine, a potent antiseptic and disinfectant, has been a cornerstone in healthcare and personal hygiene for decades. Its broad-spectrum antimicrobial properties make it an essential component in various medical and consumer products.

Global Market Size and Growth

The global povidone-iodine market has been experiencing steady growth, driven by several key factors. As of 2021, the market was valued at $152.6 million and is projected to reach $242.2 million by 2031, growing at a Compound Annual Growth Rate (CAGR) of 4.7% from 2022 to 2031[4].

Key Drivers of Market Growth

Increasing Awareness of Infection Control

The rising awareness of infection control and the need for efficient disinfectants are primary drivers of the povidone-iodine market. The COVID-19 pandemic has significantly heightened the importance of antiseptics and disinfectants, leading to increased demand for povidone-iodine in healthcare settings and personal hygiene products[1][4].

Healthcare-Associated Infections (HAIs)

The prevalence of HAIs is a significant concern globally. According to the Centers for Disease Control and Prevention (CDC), one in every 31 hospital patients contracts at least one HAI on any given day. This has led to a surge in the use of povidone-iodine as an effective antiseptic in hospital settings[1].

Growing Number of Surgical Procedures

The increasing number of surgical procedures worldwide is another factor driving the demand for povidone-iodine. It is widely used as a pre-operative skin disinfectant. The number of surgical procedures performed worldwide rose from 226.4 million in 2004 to 312.9 million in 2012, and this number is expected to continue rising[1].

Expanding Healthcare Infrastructure in Asia Pacific

The Asia Pacific region, particularly countries like China, is experiencing substantial growth in healthcare infrastructure and spending. This growth has increased the demand for medical products, including povidone-iodine. Health expenditure in the Western Pacific Region rose from 6.4% of GDP in 2000 to 7.4% in 2018, indicating a robust market for antiseptics[1].

Regional Dynamics

North America

North America, especially the United States, is expected to exhibit substantial growth in the povidone-iodine market. The rising prevalence of chronic wounds, particularly those associated with diabetes, is driving demand for wound care treatments, including povidone-iodine-based solutions. Approximately 34.2 million Americans had diabetes in 2018, and about 25% of diabetics will develop a foot ulcer during their lifetimes[1].

Asia Pacific

The Asia Pacific region is also a significant market due to its expanding healthcare infrastructure and increasing health expenditure. Countries like China are driving the demand for povidone-iodine with their growing healthcare needs[1][3].

Market Segmentation

By Formulation Type

Povidone-iodine is available in various formulations, including scrubs, topical solutions, ointments, and others. Each formulation caters to different applications, such as skin sterilization, instrument sterilization, and disinfectants[4].

By Application

  • Skin Sterilization: Povidone-iodine is widely used for pre-operative skin preparation and wound care.
  • Instrument Sterilization: The COVID-19 pandemic has increased the demand for instrument sterilization, further boosting the market.
  • Disinfectant: It is used in various disinfectant products for both medical and personal use[4].

Price Projections

Given the projected market growth, the prices of povidone-iodine are likely to remain stable or see a moderate increase. The demand for antiseptic and disinfectant products is expected to continue, but the competitive nature of the market and the presence of established players like 3M Company, Avrio Health L.P., and BASF SE may help stabilize prices[2][4].

Impact of COVID-19

The COVID-19 pandemic has significantly impacted the povidone-iodine market by increasing the demand for instrument sterilization and personal hygiene products. This surge in demand has been a key factor in the market's growth during the pandemic period[1][4].

Key Players

The povidone-iodine market is dominated by several established players, including:

  • 3M Company
  • Avrio Health L.P.
  • BASF SE

These companies have a strong presence in the market and are driving innovation and supply to meet the growing demand for povidone-iodine[4].

Future Outlook

The future outlook for the povidone-iodine market is positive, driven by increasing awareness of hygiene and infection prevention, the growing number of surgical procedures, and the expansion of healthcare infrastructure. As the global healthcare sector continues to prioritize infection control and preventive healthcare measures, the demand for povidone-iodine is expected to continue growing.

"The rising awareness of infection control, the need for efficient disinfectants in a variety of industries, and the necessity of povidone iodine as a strong antiseptic in healthcare settings especially in the wake of the COVID-19 pandemic are the main factors propelling the povidone iodine market."[1]

Key Takeaways

  • The global povidone-iodine market is projected to grow from $152.6 million in 2021 to $242.2 million by 2031.
  • The market is driven by increasing awareness of infection control, the growing number of surgical procedures, and expanding healthcare infrastructure.
  • The Asia Pacific and North American regions are significant markets due to their healthcare needs and infrastructure growth.
  • Povidone-iodine prices are expected to remain stable or see a moderate increase due to market demand and competition.
  • Established players like 3M Company, Avrio Health L.P., and BASF SE are key drivers of the market.

FAQs

1. What is the projected growth rate of the povidone-iodine market from 2022 to 2031? The povidone-iodine market is projected to grow at a CAGR of 4.7% from 2022 to 2031[4].

2. What are the main drivers of the povidone-iodine market? The main drivers include increasing awareness of infection control, the growing number of surgical procedures, and the expansion of healthcare infrastructure, particularly in the Asia Pacific region[1][4].

3. How has the COVID-19 pandemic impacted the povidone-iodine market? The COVID-19 pandemic has increased the demand for instrument sterilization and personal hygiene products, significantly boosting the market for povidone-iodine[1][4].

4. Which regions are expected to exhibit substantial growth in the povidone-iodine market? North America and the Asia Pacific region are expected to exhibit substantial growth due to their healthcare needs and infrastructure expansion[1][3].

5. What are the common formulations of povidone-iodine? Povidone-iodine is available in various formulations, including scrubs, topical solutions, ointments, and others[4].

Sources

  1. Verified Market Research - Povidone Iodine Market Size, Share, Trends, Scope & Forecast
  2. DrugPatentWatch - Drug prices and trends for POVIDONE-IODINE
  3. SkyQuestT - Povidone Iodine Market Report: Size, Share & Forecast | 2031
  4. Allied Market Research - Povidone Iodine Market Size & Share | Forecast Report 2031

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.